DMRA · Damora Therapeutics, Inc.
$29.99
-3.00 (-9.09%)
At close · Jul 22
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 12, 2026
Market Cap
$1.85B
Shares
61.55M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-29 | 571,067 | $25.36 | $14,482,259 |
| 2026-06-25 | 1,132 | $22.00 | $24,904 |
| 2026-06-24 | 1,700 | $22.94 | $38,998 |
| 2026-06-23 | 16,599 | $23.89 | $396,550 |
| 2026-06-22 | 7,247 | $21.23 | $153,854 |
| 2026-06-18 | 4,383 | $21.42 | $93,884 |
| 2026-06-17 | 2,493 | $20.59 | $51,331 |
| 2026-06-15 | 1,556 | $20.78 | $32,334 |
| 2026-06-12 | 4 | $21.36 | $85 |
| 2026-06-11 | 6,419 | $20.15 | $129,343 |
| 2026-06-09 | 1,840 | $20.91 | $38,474 |
| 2026-06-08 | 3,300 | $21.01 | $69,333 |
| 2026-06-03 | 3,635 | $22.95 | $83,423 |
| 2026-06-01 | 3,182 | $24.88 | $79,168 |
| 2026-05-28 | 1,521 | $25.21 | $38,344 |
| 2026-05-27 | 2,442 | $25.89 | $63,223 |
| 2026-05-26 | 1,678 | $25.30 | $42,453 |
| 2026-05-18 | 2,502 | $24.60 | $61,549 |
| 2026-05-14 | 4,406 | $24.16 | $106,449 |
| 2026-04-28 | 48 | $25.50 | $1,224 |
| 2026-04-24 | 1,677 | $25.42 | $42,629 |
Showing 1–21 of 21 settlements